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The history of the pulmonary artery catheter spans almost
90 years from the first reported cardiac catheterization by
Werner Forssmann (on himself!) in 1929. Some 25 years
later, a balloon-tipped catheter was developed by Lategola
and Rahn [1] and used in dogs, but the name of the catheter
(and much of the credit for its invention) went to Swan and
Ganz, whose now famous paper on the use of a balloon-
tipped catheter to catheterize the pulmonary artery was
published in 1970 [2]. The innovative use of the balloon to
guide the catheter made this a huge advance for cardiology
and haemodynamic monitoring and management. Since that
date, the pulmonary artery (Swan-Ganz) catheter (PAC) has
changed little in size or structure, and has become one of the
most widely used pieces of equipment in the intensive care
unit (ICU).
However, in recent years, with the push to make medical care
as noninvasive as possible and with the development of
possible alternative, less invasive means of monitoring, the
role of the PAC has come under close scrutiny. Intensivists
are divided in their opinions, split into those who maintain that
the haemodynamic data provided by the PAC aid in diagnosis
and patient management, and those who believe that the
complications and limitations outweigh the benefits.
Increasingly, evidence does seem to suggest that patients
managed with a PAC have similar outcomes to those without
[3-7], although some studies have shown worse outcomes
[8,9] and others improved outcomes [10]. The studies that
have been conducted have used either complex statistical
methodology to compare cohorts of patients [7,9,11] or have
randomized patients to be managed with or without a PAC
[3-6,12].
In a recent observational study conducted across Europe and
including 3147 patients, a cohort of 481 patients who had a
PAC inserted was compared with a cohort of patients with no
PAC [7]. PAC use was not an independent risk factor for
60-day mortality in multivariate analysis, and in 453
propensity-matched pairs ICU and hospital mortality rates
were similar between groups (PAC use versus no PAC use:
ICU mortality 26.7% versus 26.3%; hospital mortality 31.4%
versus 32.8%; not significant). In the most recent randomized
study, 1041 ICU patients were randomly assigned to
treatment with or without a PAC [6]. Physicians managing
patients without a PAC were allowed to use alternative
monitoring equipment (selected for 79% of patients) if they
wished. There were no differences in hospital mortality (68%
versus 66%; P = 0.039), hospital length of stay, or days of
organ support between patients managed with and those
managed without a PAC, and in a cost-effectiveness analysis
the authors concluded that there would be considerable
savings if the PAC were to be withdrawn from clinical use.
So, amidst all of these gloomy reports, does the PAC have a
future or is it doomed to gather dust at the back of ICU
equipment cupboards before reaching its final resting place
as a curiosity in museums of medical history? I believe that
the PAC still has a place in today’s ICU, and that the
information it provides can be integrated with that derived
from newer equipment to optimize patient care. The PAC is a
monitoring tool; if it is used to direct therapy and there is no
improvement in outcome, then the therapy does not help. We
know that PAC-derived data can prompt therapy to improve
patient outcomes [13] but such improvements are not always
achieved (e.g. sometimes physicians do not make the
necessary changes to their therapy as suggested by the
measurements) or indeed there may be overzealous
application of therapies (e.g. fluid challenge for low cardiac
filling pressure when there is no need for it). Thus, there is a
need for better strategies based on the measurements
obtained.
Many items of monitoring equipment widely used in the ICU
have never undergone randomized controlled testing, including
the electrocardiogram, yet we perform many electro-
cardiograms every day! Any tool is only as good as those who
operate it. We need better, and continuing, training in
haemodynamic monitoring, which has evolved over time (and
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continues to do so); initially filling pressures were monitored,
then cardiac output measurements were added, and then
mixed venous oxygen saturation (SvO2) measurements (and
there are still people who do not measure SvO2). Today, we
propose the reverse; treatment strategies should be directed
first by SvO2, then by cardiac output and finally by pulmonary
artery pressures [14] (Figure 1). We must also emphasize
that PAC monitoring has evolved toward complete,
‘continuous’ measurements not only of cardiac output and
ejection fraction but also of SvO2. This might dramatically
influence our understanding of clinical situations as compared
with past times when measurements obtained with a PAC
were taken and considered only two or three times per day at
best! It is difficult to imagine monitoring electrocardiography
or pulse oximetry only two to three times per day. In my view,
the ability to take continuous measurements of two or more
crucial physiological parameters will make the PAC a unique
monitoring tool for years to come – one that is very different
from other techniques such as diagnostic echocardiography.
In this supplement we explore some of the key issues
surrounding the current and future role of the PAC and
application of PAC-derived data in ICU patients; the reviews
contained herein will, I believe, help as we struggle to
integrate the PAC with newer technologies.
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Figure 1
Suggested protocol for resuscitation using PAC-derived data. O2ER,
oxygen extraction ratio; PAC, pulmonary artery catheter; PAOP,
pulmonary artery occlusion pressure; PEEP, positive end-expiratory
pressure; SaO2, arterial oxygen saturation; SvO2, mixed venous oxygen
saturation; VO2, oxygen consumption. From Pinsky and Vincent [14],
with permission.